Company · CIK 0001162194 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
STANDARD BIOTOOLS INC. · LAB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2015 SForm 4 → | Feb 4, 7:22 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | $38.15 | $228,911 | 3,380 | −64.0% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 7:22 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | $4.45 | $26,677 | 9,380 | — | plan? |
| Jan 15, 2015 SForm 4 → | Jan 20, 6:11 pm EST | William Maxwell SmithEVP, LEGAL AFFAIRS & GC | 3,000 | $34.24 | $102,720 | 726 | −80.5% | plan? |
| Jan 15, 2015 MForm 4 → | Jan 20, 6:11 pm EST | William Maxwell SmithEVP, LEGAL AFFAIRS & GC | 3,000 | $4.08 | $12,248 | 3,726 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 8:15 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | $33.37 | $200,212 | 3,380 | −64.0% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 8:15 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | $4.45 | $26,677 | 9,380 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2015 MForm 4 → | Mar 4, 8:04 pm EST | Robert C JonesEVP, RESEARCH & DEVELOPMENT | 3,000 | — | — | 5,701 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 8:03 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | — | — | 11,261 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 8:37 pm EST | Mai Chan YowSee Remarks | 350 | — | — | 4,084 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 8:29 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 1,625 | — | — | 18,959 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 8:28 pm EST | William Maxwell SmithEVP, LEGAL AFFAIRS & GC | 350 | — | — | 4,084 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 8:22 pm EST | Robert C JonesEVP, RESEARCH & DEVELOPMENT | 350 | — | — | 4,084 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 8:20 pm EST | Vikram JogCHIEF FINANCIAL OFFICER | 350 | — | — | 4,084 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 8:19 pm EST | Fredric T WalderCHIEF OPERATING OFFICER | 350 | — | — | 4,084 | — | |
| Feb 19, 2015 MForm 4 → | Feb 23, 6:15 pm EST | Samuel D ColellaDirector | 44,540 | — | — | 0 | — | |
| Feb 18, 2015 MForm 4 → | Feb 20, 6:12 pm EST | Samuel D ColellaDirector | 8,800 | — | — | 3,200 | — | |
| Feb 18, 2015 MForm 4 → | Feb 20, 6:11 pm EST | William Maxwell SmithEVP, LEGAL AFFAIRS & GC | 3,000 | — | — | 2,327 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 7:41 pm EST | Robert C JonesEVP, RESEARCH & DEVELOPMENT | 4,900 | — | — | 8,701 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 7:56 pm EST | Robert C JonesEVP, RESEARCH & DEVELOPMENT | 13,100 | — | — | 13,601 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 7:54 pm EST | Vikram JogCHIEF FINANCIAL OFFICER | 3,950 | — | — | 12,501 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 7:22 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | — | — | 5,701 | — | |
| Jan 15, 2015 MForm 4 → | Jan 20, 6:11 pm EST | William Maxwell SmithEVP, LEGAL AFFAIRS & GC | 3,000 | — | — | 5,327 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 8:15 pm EST | Gajus Vincent WorthingtonPRESIDENT & CEO, Director | 6,000 | — | — | 142 | — |